Delivery Order SPE2DB20D3303-SPE2DB23FA0TB
Award Date 8/16/23
Potential Completion Date 8/17/23
Potential Value $257
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $64,170 to Amerisourcebergen Drug Corporation for the supply of Qsymia 3.75 MG-23 MG capsules. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 30 capsules to a location in Conshohocken, Pennsylvania between July 7-10, 2023. The Defense Logistics Agency is a combat logistics support agency within the Department of Defense responsible for worldwide logistics support. This delivery order was...
- The Defense Logistics Agency Troop Support Medical awarded a $1,709.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of Qsymia 7.5 mg-46 mg to be delivered from their Conshohocken, Pennsylvania location by September 27, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. The Defense Logistics Agency manages the Department of Defense's global supply chain and supports...
- The Defense Logistics Agency awarded a $204.52 delivery order to Amerisourcebergen Drug Corporation for the supply of 30 capsules of Qsymia 15 mg-92 mg to support the Department of Defense. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility under a firm fixed price contract running from September 20th through 21st, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $763 to Amerisourcebergen Drug Corporation to supply 30 capsules of Qsymia (7.5 mg-46 mg) on July 19, 2023 for delivery by July 20, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will perform under the contract from its location in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) valued at $1,045.63 for Qsymia 15 mg-92 mg capsules (30-count). The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was structured as a firm fixed price contract with no set-aside designation. The place of performance is the vendor's Conshohocken facility, where...
- The Defense Logistics Agency awarded a $1,547.92 delivery order to AmerisourceBergen Drug Corp for QSYMIA 7.5 MG-46 MG capsules (30-count units), a pharmaceutical product used in weight management treatment. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Qsymia 7.5 mg-46 mg capsule in 30-count packages. The $3,150.08 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 8, 2025, for supply of Qsymia 3.75 mg-23 mg capsules in a 30-count package. This is a firm fixed-price delivery order with a ceiling value of $1,271.45 and an ultimate completion date of December 9, 2025. The contract was competitively awarded with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $204,520 delivery order to Amerisourcebergen Drug Corporation for Qsymia 11.25 mg-69 mg capsules. Under this firm fixed price contract, Amerisourcebergen will provide 30 capsules of the appetite suppressant and anti-obesity drug to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from August 14 to 15, 2023. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a delivery order valued at $1,600.78 to AmerisourceBergen Drug Corp for the supply of Qsymia 3.75mg-23mg tablets (30-count) on January 6, 2026, with completion targeted for January 7, 2026. This non-set-aside contract employs firm fixed-price pricing and is performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB23FA0TBDelivery Order
The Defense Logistics Agency awarded a $256,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Qsymia 3.75 MG-23 MG capsules. Under this order, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania by August 17, 2023 to support the Defense Logistics Agency's medical supply needs. As a top 10 federal contractor, Amerisourcebergen regularly fulfills delivery orders for prescription drugs and other pharmaceutical products under DLA's Prime Vendor Program on an as-needed basis. No subcontractors or set aside designations were identified for this particular award.
Generated 12/17/23, 1:24 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $257 | 8/16/23 |